Position in OGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$41,966,972
+$22,635,326 QoQ
Shares Held
3,099,481
-4.0% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#17
of 626 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $3,146,467,914 across 15 Drug Manufacturers - General names. OGN ranks #12 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
21,818,803 | $525,396,775 | |
| 2 | AMGN |
Amgen Inc
|
1,131,395 | $409,700,757 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,991,633 | $377,962,913 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
5,981,822 | $344,672,583 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,591,856 | $333,053,496 | |
| 6 | JNJ |
Johnson & Johnson
|
1,284,877 | $326,320,211 | |
| 7 | LLY |
ELI LILLY & Co
|
217,393 | $260,747,707 | |
| 8 | ABBV |
AbbVie Inc.
|
800,818 | $201,517,841 |
All Filings in OGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,966,972 | 3,099,481 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $19,331,646 | 3,227,320 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,992,620 | 1,812,081 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $23,123,406 | 2,165,113 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $17,385,202 | 1,795,992 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $30,731,709 | 2,063,916 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $23,940,214 | 1,604,572 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $31,349,306 | 1,638,751 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $26,392,023 | 1,274,977 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $17,921,889 | 953,292 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $15,402,348 | 1,068,124 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,440,280 | 716,606 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $19,322,293 | 928,510 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,694,095 | 837,334 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $25,907,979 | 927,604 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $16,260,683 | 694,901 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $45,649,946 | 1,352,591 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $39,148,007 | 1,120,756 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $20,212,405 | 663,790 | Shares | Sole | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||